This inventor holds 1 USPTO granted patent. Top assignee: Pasteur Merieux Serums Et Vaccins. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Pierre L Fournier: Innovator in Albumin Isolation
Introduction
Pierre L Fournier is a notable inventor based in Lyons, France. He has made significant contributions to the field of biochemistry, particularly in the isolation of human albumin. His innovative approach has implications for various medical applications, enhancing the purity and efficacy of albumin used in treatments.
Latest Patents
Fournier holds a patent for a process titled "Process for isolating human albumin from supernatant IV." This patent describes a method that involves a single step on a hydrophilic anion exchange column, where albumin binds to the column followed by elution. Additionally, it includes a step on a hydrophobic anion exchange column. The albumin obtained through this process boasts a purity greater than 99% as determined by cellulose acetate electrophoresis, ensuring it is free from impurities detected by crossed immunoelectrophoresis and free from polymers.
Career Highlights
Pierre L Fournier is associated with Pasteur Merieux Serums Et Vaccins, a company renowned for its contributions to vaccine development and biopharmaceuticals. His work has been instrumental in advancing techniques for protein purification, which is crucial for therapeutic applications.
Collaborations
Fournier has collaborated with esteemed colleagues such as Michel G Grandgeorge and Jean-Luc B Veron. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of biochemistry.
Conclusion
Pierre L Fournier's contributions to the isolation of human albumin represent a significant advancement in biochemistry. His innovative methods and collaborations continue to influence the field, paving the way for improved medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile